University of Washington-ko ikertzaileekin lankidetzan egindako argitalpenak (5)

2024

  1. An Early Treatment With BKI-1748 Exhibits Full Protection Against Abortion and Congenital Infection in Sheep Experimentally Infected With Toxoplasma gondii

    Journal of Infectious Diseases, Vol. 229, Núm. 2, pp. 558-566

2021

  1. One health therapeutics: Target-Based drug development for cryptosporidiosis and other apicomplexa diseases

    Veterinary Parasitology, Vol. 289

2019

  1. Treatment with Bumped Kinase Inhibitor 1294 Is Safe and Leads to Significant Protection against Abortion and Vertical Transmission in Sheep Experimentally Infected with Toxoplasma gondii during Pregnancy

    Antimicrobial Agents and Chemotherapy, Vol. 63, Núm. 7

2018

  1. Safety and efficacy of the bumped kinase inhibitor BKI-1553 in pregnant sheep experimentally infected with Neospora caninum tachyzoites

    International Journal for Parasitology: Drugs and Drug Resistance, Vol. 8, Núm. 1, pp. 112-124

2017

  1. Development of a murine vertical transmission model for Toxoplasma gondii oocyst infection and studies on the efficacy of bumped kinase inhibitor (BKI)-1294 and the naphthoquinone buparvaquone against congenital toxoplasmosis

    Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 8, pp. 2334-2341